Denise M. Pothier

Array ( [id] => 7474484 [patent_doc_number] => 20040097494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'New derivatives of N-(iminomethy)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them' [patent_app_type] => new [patent_app_number] => 10/612646 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19282 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097494.pdf [firstpage_image] =>[orig_patent_app_number] => 10612646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436504 [patent_doc_number] => 20040002485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Heteroaromatic derivatives having an inhibitory activity against HIV integrase' [patent_app_type] => new [patent_app_number] => 10/463816 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 143098 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002485.pdf [firstpage_image] =>[orig_patent_app_number] => 10463816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702184 [patent_doc_number] => 20030225064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Sulfonylbenzene compounds as anti-inflammatory/analgesic agents' [patent_app_type] => new [patent_app_number] => 10/465767 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86819 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225064.pdf [firstpage_image] =>[orig_patent_app_number] => 10465767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1130967 [patent_doc_number] => 06787536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-07 [patent_title] => 'Hydroxamic acid derivatives' [patent_app_type] => B2 [patent_app_number] => 10/460894 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16678 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 489 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/787/06787536.pdf [firstpage_image] =>[orig_patent_app_number] => 10460894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1189093 [patent_doc_number] => 06734185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-05-11 [patent_title] => 'Pyrrolo3,4-dpyrimidines as corticotropin releasing factor (CRF) antagonists' [patent_app_type] => B2 [patent_app_number] => 10/457130 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12901 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/734/06734185.pdf [firstpage_image] =>[orig_patent_app_number] => 10457130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7454170 [patent_doc_number] => 20040067994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'BICYCLIC HETEROCYCLIC SUBSTITUTED PHENYL OXAZOLIDINONE ANTIBACTERIALS, AND RELATED COMPOSITIONS AND METHODS' [patent_app_type] => new [patent_app_number] => 10/457271 [patent_app_country] => US [patent_app_date] => 2003-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19676 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067994.pdf [firstpage_image] =>[orig_patent_app_number] => 10457271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1164173 [patent_doc_number] => 06759402 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'Cyclic felbamate derived compounds' [patent_app_type] => B2 [patent_app_number] => 10/456117 [patent_app_country] => US [patent_app_date] => 2003-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8967 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759402.pdf [firstpage_image] =>[orig_patent_app_number] => 10456117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1062930 [patent_doc_number] => 06849617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-02-01 [patent_title] => 'Tissue factor antagonists and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/445205 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11466 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 406 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/849/06849617.pdf [firstpage_image] =>[orig_patent_app_number] => 10445205 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1142084 [patent_doc_number] => 06777404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-17 [patent_title] => 'Use of corticotropin releasing factor antagonists and related compositions' [patent_app_type] => B2 [patent_app_number] => 10/413879 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30647 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777404.pdf [firstpage_image] =>[orig_patent_app_number] => 10413879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7363689 [patent_doc_number] => 20040014973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Pyridin-4-YL or pyrimidin-4-YL substituted pyrazines' [patent_app_type] => new [patent_app_number] => 10/413245 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16712 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014973.pdf [firstpage_image] =>[orig_patent_app_number] => 10413245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449839 [patent_doc_number] => 20040009997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Crystalline bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl) amino]pyrimidin -5-yl] (3R,5S)-3, 5-dihydroxyhept -6-enoic acid]calcium salt' [patent_app_type] => new [patent_app_number] => 10/410650 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1374 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009997.pdf [firstpage_image] =>[orig_patent_app_number] => 10410650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404095 [patent_doc_number] => 20040023956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Oxazinones and methods for their use and synthesis' [patent_app_type] => new [patent_app_number] => 10/411547 [patent_app_country] => US [patent_app_date] => 2003-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16781 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023956.pdf [firstpage_image] =>[orig_patent_app_number] => 10411547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822155 [patent_doc_number] => 20030220316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Azacyclic compounds' [patent_app_type] => new [patent_app_number] => 10/409782 [patent_app_country] => US [patent_app_date] => 2003-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 50819 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220316.pdf [firstpage_image] =>[orig_patent_app_number] => 10409782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1196983 [patent_doc_number] => 06727239 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Derivatives of 2-aminopyridines, their use as medicaments and pharmaceutical compositions containing them' [patent_app_type] => B1 [patent_app_number] => 10/405828 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727239.pdf [firstpage_image] =>[orig_patent_app_number] => 10405828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1157123 [patent_doc_number] => 06762198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Dihetero-substituted metalloprotease inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/396775 [patent_app_country] => US [patent_app_date] => 2003-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23384 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762198.pdf [firstpage_image] =>[orig_patent_app_number] => 10396775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702240 [patent_doc_number] => 20030225120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Dihydropyridine soft drugs, and related compositions and methods' [patent_app_type] => new [patent_app_number] => 10/392038 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9215 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225120.pdf [firstpage_image] =>[orig_patent_app_number] => 10392038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664588 [patent_doc_number] => 20030203914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => '2-Pyridinylguanidine urokinase inhibitors' [patent_app_type] => new [patent_app_number] => 10/386888 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15843 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20030203914.pdf [firstpage_image] =>[orig_patent_app_number] => 10386888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639761 [patent_doc_number] => 20030212062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Morpholinone and morpholine derivatives and uses thereof' [patent_app_type] => new [patent_app_number] => 10/386083 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24020 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212062.pdf [firstpage_image] =>[orig_patent_app_number] => 10386083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1265068 [patent_doc_number] => 06660740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-09 [patent_title] => 'Sorbitol dehydrogenase inhibitors' [patent_app_type] => B1 [patent_app_number] => 10/384424 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88950 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/660/06660740.pdf [firstpage_image] =>[orig_patent_app_number] => 10384424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397994 [patent_doc_number] => 20040038970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Beta-carboline compounds' [patent_app_type] => new [patent_app_number] => 10/383949 [patent_app_country] => US [patent_app_date] => 2003-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17549 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038970.pdf [firstpage_image] =>[orig_patent_app_number] => 10383949 [rel_patent_id] =>[rel_patent_doc_number] =>)